28
Participants
Start Date
May 31, 2007
Primary Completion Date
December 31, 2008
Study Completion Date
December 31, 2008
XL844
Gelatin capsules supplied as 5-mg, 25-mg, and 100-mg strengths; twice-weekly dosing.
Gemcitabine
once-weekly 30-minute IV infusion
Memorial Sloan-Kettering Cancer Center, New York
M.D. Anderson Cancer Center, Houston
Lead Sponsor
Exelixis
INDUSTRY